Allied Market Research
Loading...
0
New
New
2022
Mouth Ulcers Treatment Market

Mouth Ulcers Treatment Market by Drug Class (Analgesic & Corticosteroids, Antihistamine, Antimicrobial, and Anesthetic), Formulation Type (Sprays, Mouthwash, Gels, and Lozenges), and Indication (Aphthous Stomatitis, Oral Lichen Planus, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A01173
Pages: 245
Sep 2021 | 3592 Views
   
Author(s) : Apoorva Srivastava , Onkar Sumant
Tables: 121
Charts: 39
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Mouth Ulcers Treatment Market

Request Now !

The global mouth ulcers treatment market was valued at 1,655.00 million in 2020, and is projected to reach $2,375.70 million by 2030, registering a CAGR of 3.8% from 2021 to 2030. Mouth ulcers are painful breaks, sores or lesions that occur in the mucous membrane of the oral cavity's soft tissues, which include the lips, cheeks, gums, tongue, floor, and roof. It can also be seen on the esophagus. It is often unpleasant light or yellow lesions with a crimson outer ring that is painful and cause discomfort while drinking and eating food.

COVID Banner: The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global mouth ulcers treatment market. There were certain cases of people developing ulcers due to the weakened immune system mainly due to lack of vitamins and minerals in the body due tocaused by the COVID-19 infection.

Aphthous stomatitis, commonly known as recurrent aphthous ulcers or canker sores, is a frequent oral mucosal disease seen by doctors and dentists. Aphthous ulcers are tiny, shallow lesions that form on the soft tissues of the mouth or at the base of the gums. Canker sores, unlike cold sores, do not appear on the surface of the lips and are not communicable. They are often merely a mild annoyance that lasts a week or two. They are exceedingly frequent, occurring in conjunction with a broad variety of illnesses and by a number of processes, although there is generally no significant underlying cause. They can be painful and make eating and talking difficult.

Mouth-Ulcers-Treatment-Market-2021-2030

Get more information on this report : Request Sample Pages

The demand for mouth ulcers treatment has been on a rise due to increasing prevalence of mouth ulcers due to rise in tobacco consumption globally and smoking cessation, as smoking cessation causes mouth ulcers and occur often in smokers. Therefore, this increases the occurrences of mouth ulcers due to tobacco stomatitis or smoker's palate, (inflammation of mucus membranes in oral cavity), which is expected to propel the market growth of mouth ulcers treatment.

Moreover, use of chemical-based toothpaste and consumption of more citric foods or acidic fruits and vegetables, such as lemons, oranges, pineapples, apples, figs, tomatoes, strawberries, further increase the chances of mouth ulcers. Therefore, rising tobacco usage, smoking cessation, chemical-based toothpaste, and acidic foods are the factors that are driving the growth of the mouth ulcers treatment market.

Oral hygiene is the practice of keeping one's mouth clean, free of disease, and other dental conditions. There has been an increasing demand for oral and dental hygiene mainly due to self-consciousness. Mouth ulcers occur often as a result of infection from plaque bacteria on the teeth; poor oral hygiene also plays a contributory role in the development of mouth ulcers. Self-consciousness among individuals for oral and dental hygiene has been on rise, including orthodontic, periodontics, endodontic, and various other cosmetic dentistry services. Injury from orthodontic braces, which are used for alignment of the teeth, poor-fitting dentures, and other apparatus that may rub against the mouth and gums is one of the causes of occurrence of mouth ulcers.

Various bacterial, viral, and fungal infections caused by poor oral hygiene can trigger mouth ulcer while minor injuries due to sports or any other activities in oral cavity also lead to mouth ulcers and infections. Canker ulcers also occur due to certain nutritional deficiencies. Thus, various factors, such as mouth ulcers due to orthodontics braces, minor injuries and various initiatives by the government and dental associations for the importance of oral hygiene, are expected to drive the mouth ulcers treatment market. Therefore, it is expected to create a positive impact during the forecast period.

Increase in overall population, especially the geriatric, has led to the increase in cases of people having mouth ulcers or sores. Mouth ulcers as a result of various medical condition or nutritional deficiencies, such as celiac or Crohn's disease, vitamin B12 or iron deficiency, or a weakened immune system, in elderly population may all trigger ulcers or sores to form. These oral health problems and illnesses connected with aging are frequently complicated and can have a negative impact on one's quality of life. Any oral diseases or conditions associated with aging are complex and can have a significant effect on the quality of life for geriatric population. 

In addition, increasing overall population specific geriatric and unhealthy lifestyle changes, stress, anxiety, tobacco use, and consumption of more chemical & acidic-based food in younger generation led to repetitive occurrences of mouth ulcers. Thus, all these factors are expected to contribute toward driving the mouth ulcers treatment market.

In addition, there are opportunities in untapped, emerging markets with high potential due to improved healthcare infrastructure, increase in unmet healthcare needs, and rise in prevalence of mouth ulcers. Availability of various pharmaceutical-based ulcer treatment products, such as drugs, including analgesics, corticosteroids, antihistamine, antimicrobial, anesthetic, various applicants in the form of sprays, mouthwash, gels, lozenges, ointments, and others at affordable cost and their availability as an OTC product is an emerging opportunity for the key players of the market to invest in the mouth ulcers treatment market, which will further accelerate the expansion of the market, thereby offering significant growth opportunities for the market during the forecast period.

Mouth Ulcers Treatment Market Segmentation

The mouth ulcers treatment market is segmented on the basis of drug class, formulation type, indication, and region. On the basis of drug type, the market is categorized into analgesics & corticosteroids, antihistamine, antimicrobial, and anesthetic. By formulation type, the market is divided into sprays, mouthwash, gels, and lozenges. By indication, the market is classified into aphthous stomatitis, oral lichen planus, and others. 
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).

Segment review

Depending on drug class, the anesthetic segment dominated the market in 2020, and is expected to continue this trend during the forecast period due to increase in demand for painkillers for temporarily reducing unbearable pain and discomforts due to mouth ulcers and also their anti-inflammatory properties. 

Mouth Ulcers Treatment Market
By Drug Class

Your browser does not support the canvas element.

Anesthetic segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of formulation type, the gels segment led the market in 2020, and is expected to retain its dominance during the forecast period, owing to its popularity due to quick healing formulations, ease of availability, immediate anti-inflammatory, and anti-swelling qualities.

Mouth Ulcers Treatment Market
By Formulation Type

Your browser does not support the canvas element.

Gels segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

By indication, the aphthous stomatitis segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.

North America accounted for a majority of the global mouth ulcers treatment market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of mouth ulcers, presence of key players, increase in healthcare expenditure, advancements in technology, and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness the highest CAGR from 2021 to 2030, owing to increase in overall population and rise in trend of self-medication in the region. Furthermore, innovation and development are anticipated to further fuel the growth in this region in the near future. 

Mouth Ulcers Treatment Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.8% during the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global mouth ulcers treatment market include Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, and 3M.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the mouth ulcers treatment market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Key Market Segments

By Drug Class

  • Analgesics and Corticosteroids 
  • Antihistamine
  • Antimicrobial
  • Anesthetic

By Formulation Type

  • Sprays
  • Mouthwash
  • Gels
  • Lozenges

By Indication

  • Aphthous Stomatitis
  • Oral Lichen Planus
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players

  • Blistex Inc.
  • Bristol-Myers Squibb Company
  • Church & Dwight Co, Inc.
  • Colgate Palmolive Company
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline, plc
  • Patterson Companies, Inc.
  • Pfizer Inc.
  • Prince Care Pharma Private Limited
  • 3M
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of mouth ulcers
3.5.1.2.Rising dental and oral hygiene awareness
3.5.1.3.Increase in overall population

3.5.2.Restraint

3.5.2.1.Lack of awareness and availability of traditional substitutes

3.5.3.Opportunity

3.5.3.1.Growing opportunities in emerging market due to innovative products

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the mouth ulcers treatment market

CHAPTER 4:MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS

4.1.Overview

4.1.1.Market size and forecast

4.2.Analgesics and Corticosteroids

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market analysis, by indication

4.3.Antihistamine

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market analysis, by indication

4.4.Antimicrobial

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market analysis, by indication

4.5.Anesthetic

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.5.4.Market analysis, by indication

CHAPTER 5:MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Sprays

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Mouthwash

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Gels

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Lozenges

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

CHAPTER 6:MOUTH ULCERS TREATMENT MARKET, BY INDICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Aphthous Stomatitis

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Oral Lichen Planus

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Others

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:MOUTH ULCERS TREATMENT MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America Mouth Ulcers Treatment market, by drug class
7.2.3.North America Mouth Ulcers Treatment market, by formulation type
7.2.4.North America Mouth Ulcers Treatment market, by indication
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. Mouth Ulcers Treatment market, by drug class
7.2.5.1.2.U.S. Mouth Ulcers Treatment market, by formulation type
7.2.5.1.3.U.S. Mouth Ulcers Treatment market, by indication

7.2.5.2.Canada

7.2.5.2.1.Canada Mouth Ulcers Treatment market, by drug class
7.2.5.2.2.Canada Mouth Ulcers Treatment market, by formulation type
7.2.5.2.3.Canada Mouth Ulcers Treatment market, by indication

7.2.5.3.Mexico

7.2.5.3.1.Mexico Mouth Ulcers Treatment market, by drug class
7.2.5.3.2.Mexico Mouth Ulcers Treatment market, by formulation type
7.2.5.3.3.Mexico Mouth Ulcers Treatment market, by indication

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Mouth Ulcers Treatment market, by drug class
7.3.3.Europe Mouth Ulcers Treatment market, by formulation type
7.3.4.Europe Mouth Ulcers Treatment market, by indication
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany Mouth Ulcers Treatment market, by drug class
7.3.5.1.2.Germany Mouth Ulcers Treatment market, by formulation type
7.3.5.1.3.Germany Mouth Ulcers Treatment market, by indication

7.3.5.2.France

7.3.5.2.1.France Mouth Ulcers Treatment market, by drug class
7.3.5.2.2.France Mouth Ulcers Treatment market, by formulation type
7.3.5.2.3.France Mouth Ulcers Treatment market, by indication

7.3.5.3.UK

7.3.5.3.1.UK Mouth Ulcers Treatment market, by drug class
7.3.5.3.2.UK Mouth Ulcers Treatment market, by formulation type
7.3.5.3.3.UK Mouth Ulcers Treatment market, by indication

7.3.5.4.Italy

7.3.5.4.1.Italy Mouth Ulcers Treatment market, by drug class
7.3.5.4.2.Italy Mouth Ulcers Treatment market, by formulation type
7.3.5.4.3.Italy Mouth Ulcers Treatment market, by indication

7.3.5.5.Spain

7.3.5.5.1.Spain Mouth Ulcers Treatment market, by drug class
7.3.5.5.2.Spain Mouth Ulcers Treatment market, by formulation type
7.3.5.5.3.Spain Mouth Ulcers Treatment market, by indication

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe Mouth Ulcers Treatment market, by drug class
7.3.5.6.2.Rest of Europe Mouth Ulcers Treatment market, by formulation type
7.3.5.6.3.Rest of Europe Mouth Ulcers Treatment market, by indication

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Mouth Ulcers Treatment market, by drug class
7.4.3.Asia-Pacific Mouth Ulcers Treatment market, by formulation type
7.4.4.Asia-Pacific Mouth Ulcers Treatment market, by indication
7.4.5.Market size and forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Japan Mouth Ulcers Treatment market, by drug class
7.4.5.1.2.Japan Mouth Ulcers Treatment market, by formulation type
7.4.5.1.3.Japan Mouth Ulcers Treatment market, by indication

7.4.5.2.China

7.4.5.2.1.China Mouth Ulcers Treatment market, by drug class
7.4.5.2.2.China Mouth Ulcers Treatment market, by formulation type
7.4.5.2.3.China Mouth Ulcers Treatment market, by indication

7.4.5.3.Australia

7.4.5.3.1.Australia Mouth Ulcers Treatment market, by drug class
7.4.5.3.2.Australia Mouth Ulcers Treatment market, by formulation type
7.4.5.3.3.Australia Mouth Ulcers Treatment market, by indication

7.4.5.4.India

7.4.5.4.1.India Mouth Ulcers Treatment market, by drug class
7.4.5.4.2.India Mouth Ulcers Treatment market, by formulation type
7.4.5.4.3.India Mouth Ulcers Treatment market, by indication

7.4.5.5.South Korea

7.4.5.5.1.South Korea Mouth Ulcers Treatment market, by drug class
7.4.5.5.2.South Korea Mouth Ulcers Treatment market, by formulation type
7.4.5.5.3.South Korea Mouth Ulcers Treatment market, by indication

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific Mouth Ulcers Treatment market, by drug class
7.4.5.6.2.Rest of Asia-Pacific Mouth Ulcers Treatment market, by formulation type
7.4.5.6.3.Rest of Asia-Pacific Mouth Ulcers Treatment market, by indication

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Mouth Ulcers Treatment market, by drug class
7.5.3.LAMEA Mouth Ulcers Treatment market, by formulation type
7.5.4.LAMEA Mouth Ulcers Treatment market, by indication
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil Mouth Ulcers Treatment market, by drug class
7.5.5.1.2.Brazil Mouth Ulcers Treatment market, by formulation type
7.5.5.1.3.Brazil Mouth Ulcers Treatment market, by indication

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia Mouth Ulcers Treatment market, by drug class
7.5.5.2.2.Saudi Arabia Mouth Ulcers Treatment market, by formulation type
7.5.5.2.3.Saudi Arabia Mouth Ulcers Treatment market, by indication

7.5.5.3.South Africa

7.5.5.3.1.South Africa Mouth Ulcers Treatment market, by drug class
7.5.5.3.2.South Africa Mouth Ulcers Treatment market, by formulation type
7.5.5.3.3.South Africa Mouth Ulcers Treatment market, by indication

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA Mouth Ulcers Treatment market, by drug class
7.5.5.4.2.Rest of LAMEA Mouth Ulcers Treatment market, by formulation type
7.5.5.4.3.Rest of LAMEA Mouth Ulcers Treatment market, by indication

CHAPTER 8:COMPANY PROFILES

8.1.BLISTEX INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio

8.2.BRISTOL-MYERS SQUIBB COMPANY

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.CHURCH & DWIGHT CO., INC.

8.3.1.Company overview
8.3.2.Operating business segments
8.3.3.Product portfolio
8.3.4.Business performance
8.3.5.Key strategic moves and developments

8.4.COLGATE-PALMOLIVE COMPANY

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.DR. REDDY’S LABORATORIES LIMITED

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.GLAXOSMITHKLINE PLC

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.PATTERSON COMPANIES, INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.PFIZER, INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.PRINCE CARE PHARMA PVT LTD

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.10.3M COMPANY

8.10.1.Company overview

8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

LIST OF TABLES

TABLE 01.GLOBAL MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 02.ANALGESICS AND CORTICOSTEROIDS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.ANALGESICS AND CORTICOSTEROIDS MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 04.MOUTH ULCERS TREATMENT MARKET FOR ANTIHISTAMINE, BY REGION, 2020-2030 ($MILLION)
TABLE 05.ANTIHISTAMINE MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 06.MOUTH ULCERS TREATMENT MARKET FOR ANTIMICROBIAL, BY REGION, 2020-2030 ($MILLION)
TABLE 07.ANTIMICROBIAL MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 08.MOUTH ULCERS TREATMENT MARKET FOR ANESTHETIC, BY REGION, 2020-2030 ($MILLION)
TABLE 09.ANESTHETIC MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 10.GLOBAL MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 11.MOUTH ULCERS TREATMENT MARKET FOR SPRAYS, BY REGION, 2020-2030 ($MILLION)
TABLE 12.MOUTH ULCERS TREATMENT MARKET FOR MOUTHWASH, BY REGION, 2020-2030 ($MILLION)
TABLE 13.MOUTH ULCERS TREATMENT MARKET FOR GELS, BY REGION, 2020-2030 ($MILLION)
TABLE 14.MOUTH ULCERS TREATMENT MARKET FOR LOZENGES, BY REGION, 2020-2030 ($MILLION)
TABLE 15.GLOBAL MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 16.MOUTH ULCERS TREATMENT MARKET FOR APHTHOUS STOMATITIS, BY REGION, 2020-2030 ($MILLION)
TABLE 17.MOUTH ULCERS TREATMENT MARKET FOR ORAL LICHEN PLANUS, BY REGION, 2020-2030 ($MILLION)
TABLE 18.MOUTH ULCERS TREATMENT MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 19.MOUTH ULCERS TREATMENT MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 22.NORTH AMERICA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 23.NORTH AMERICA MOUTH ULCERS TREATMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 24.U.S. MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 25.U.S. MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 26.U.S. MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 27.CANADA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 28.CANADA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 29.CANADA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 30.MEXICO MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 31.MEXICO MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 32.MEXICO MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 33.EUROPE MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 34.EUROPE MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 35.EUROPE MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 36.EUROPE MOUTH ULCERS TREATMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 37.GERMANY MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 38.GERMANY MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 39.GERMANY MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 40.FRANCE MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 41.FRANCE MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 42.FRANCE MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 43.UK MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 44.UK MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 45.UK MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 46.ITALY MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 47.ITALY MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 48.ITALY MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 49.SPAIN MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 50.SPAIN MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 51.SPAIN MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 52.REST OF EUROPE MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 53.REST OF EUROPE MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 54.REST OF EUROPE MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 55.ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 56.ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 57.ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 58.ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 59.JAPAN MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 60.JAPAN MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 61.JAPAN MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 62.CHINA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 63.CHINA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 64.CHINA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 65.AUSTRALIA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 66.AUSTRALIA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 67.AUSTRALIA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 68.INDIA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 69.INDIA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 70.INDIA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 71.SOUTH KOREA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 72.SOUTH KOREA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 73.SOUTH KOREA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 77.LAMEA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 78.LAMEA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 79.LAMEA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 80.LAMEA MOUTH ULCERS TREATMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 81.BRAZIL MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 82.BRAZIL MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 83.BRAZIL MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 84.SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 85.SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 86.SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 87.SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 88.SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 89.SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 90.REST OF LAMEA MOUTH ULCERS TREATMENT MARKET, BY DRUG CLASS, 2020-2030 ($MILLION)
TABLE 91.REST OF LAMEA MOUTH ULCERS TREATMENT MARKET, BY FORMULATION TYPE, 2020-2030 ($MILLION)
TABLE 92.REST OF LAMEA MOUTH ULCERS TREATMENT MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 93.BLISTEX: COMPANY SNAPSHOT
TABLE 94.BLISTEX: OPERATING SEGMENTS
TABLE 95.BLISTEX: PRODUCT PORTFOLIO
TABLE 96.BRISTOL-MYERS.: COMPANY SNAPSHOT
TABLE 97.BRISTOL-MYERS: OPERATING SEGMENTS
TABLE 98.BRISTOL-MYERS: PRODUCT PORTFOLIO
TABLE 99.CHURCH AND DWIGHT: COMPANY SNAPSHOT
TABLE 100.BIODIEM: OPERATING SEGMENTS
TABLE 101.CHURCH AND DWIGHT: PRODUCT PORTFOLIO
TABLE 102.COLGATE-PALMOLIVE: COMPANY SNAPSHOT
TABLE 103.COLGATE-PALMOLIVE: OPERATING SEGMENTS
TABLE 104.COLGATE-PALMOLIVE: PRODUCT PORTFOLIO
TABLE 105.DR. REDDY'S: COMPANY SNAPSHOT
TABLE 106.DR. REDDY'S LABORATORIES: OPERATING SEGMENTS
TABLE 107.DR. REDDY'S LABORATORIES: PRODUCT TYPE PORTFOLIO
TABLE 108.GLAXOSMITHKLINE.: COMPANY SNAPSHOT
TABLE 109.GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 110.GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 111.PATTERSON.: COMPANY SNAPSHOT
TABLE 112.PATTERSON COMPANIES: OPERATING SEGMENTS
TABLE 113.PATTERSON: PRODUCT TYPE PORTFOLIO
TABLE 114.PFIZER INC: COMPANY SNAPSHOT
TABLE 115.PFIZER: OPERATING BUSINESS SEGMENTS
TABLE 116.PFIZER INC: PRODUCT TYPE PORTFOLIO
TABLE 117.PRINCE CARE: COMPANY SNAPSHOT
TABLE 118.PRINCE CARE: PRODUCT TYPE PORTFOLIO
TABLE 119.3M: COMPANY SNAPSHOT
TABLE 120.3M: OPERATING SEGMENTS
TABLE 121.3M: PRODUCT TYPE PORTFOLIO

LIST OF FIGURES

FIGURE 01.MOUTH ULCERS TREATMENT MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTES
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2020
FIGURE 09.IMPACT ANALYSIS
FIGURE 10.COMPARATIVE ANALYSIS OF ANALGESICS AND CORTICOSTEROIDS MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR ANTIHISTAMINE, BY COUNTRY, 2020-2030 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR ANTIMICROBIAL, BY COUNTRY, 2020-2030 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR ANESTHETIC, BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR SPRAYS, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR MOUTHWASH, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR GELS, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR LOZENGES, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR APHTHOUS STOMATITIS, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR ORAL LICHEN PLANUS, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF MOUTH ULCERS TREATMENT MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
FIGURE 21.BRISTOL-MYERS: REVENUE, 2018–2020 ($MILLION)
FIGURE 22.BRISTOL-MYERS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.CHURCH AND DWIGHT: REVENUE, 2018–2020 ($MILLION)
FIGURE 24.CHURCH AND DWIGHT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.COLGATE-PALMOLIVE: REVENUE, 2018–2020 ($MILLION)
FIGURE 26.COLGATE-PALMOLIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.DR. REDDY'S: REVENUE, 2018–2020 ($MILLION)
FIGURE 28.DR. REDDY'S: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.GLAXOSMITHKLINE PLC: REVENUE, 2018–2020 ($MILLION)
FIGURE 30.GLAXOSMITHKLINE PLC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.GLAXOSMITHKLINE PLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32.PATTERSON: REVENUE, 2018–2020 ($MILLION)
FIGURE 33.PATTERSON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.PATTERSON : REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.PFIZER INC: REVENUE, 2018–2020 ($MILLION)
FIGURE 36.PFIZER INC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.3M: REVENUE, 2018–2020 ($MILLION)
FIGURE 38.3M: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.3M: REVENUE SHARE BY REGION, 2020 (%)

 
 

This section provides the opinions of the top level CXOs in the mouth ulcers market. According to the insights of CXOs, increasing prevalence of mouth ulcers due to smoking cessation and tobacco use, citric and chemicals in foods, unhealthy lifestyles leading to stress and anxiety are all attributed toward the growth of the mouth ulcers treatment market.

The CXOs further added that technological advancements in the healthcare sector for various formulation types such as rapidly healing gels for ulcers, flavored mouthwashes for children as well as adults, and surge in oral hygiene dental visits due to self-consciousness are significantly enhancing the market growth. The emerging awareness by the government and media by public advertisements as well as key players of the market advertising their products, such as mouthwashes, is expected to further boost the market.

The mouth ulcers treatment market gains interest of healthcare companies, owing to surge in demand for instant relief from ulcer pain and discomfort caused while eating or drinking and at the same time availability of various over the counter (OTC) analgesic drugs, mouthwashes, gels, and sprays. This leads to increase in adoption of pharmaceutical uses as that of traditional remedies, thus further propelling the growth of the market.

North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of mouth ulcers, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in prevalence of mouth ulcer cases and rise in population. However, presence of substitute traditional treatments and limited accessibility to pharmaceuticals in developing and under developed countries restrain the market growth during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of mouth ulcers treatment market is $1,655.0 million in 2020.

A. The forcast period for mouth ulcers treatment market is 2021 to 2030

A. The market value of mouth ulcers treatment market in 2021 is $ 1,704.80 million.

A. The base year is 2020 in mouth ulcers treatment market

A. Top companies such as Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc., Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited and 3M. held a high market position in 2020.

A. Gel segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period. The gel based products are easy to apply, provide instant relief, at the same time come in various flavours suitable for children as well as adults, are easily available, simple to use and come at an affordable cost.

A. Rise in incidences of tobocco consumption, rrise in smoking cases, chronic disaeses in geriatric population, various chemotherapies side effects also leads to ulcers is among the key drivers propelling market growth.

A. North America is projected to account for a major share of the global mouth ulcers treatment market during the forecast period. U.S. dominated the North America mouth ulcers treatment market owing to increased tobacco consumption and increasing awareness of oral an dental hygiene across the country.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Mouth Ulcers Treatment Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers